| Esteban A Perez, CRNA | |
|
2101 Pease St, Harlingen, TX 78550-8307 | |
| (956) 389-1100 | |
| (956) 389-1800 |
| Full Name | Esteban A Perez |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 14 Years |
| Location | 2101 Pease St, Harlingen, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306177100 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 652934 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jps Health Network | Fort worth, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sound Physicians Anesthesiology Of Texas Pllc | 1254751407 | 162 |
| Endo Sedation Llc | 4789845363 | 293 |
News Archive
Among the first and most-documented symptoms of autism spectrum disorder is a child's aversion to interaction with others. Specifically, they appear uninterested in social activities and stimuli that would normally attract a young child's attention, such as watching other children play, sing or dance.
Aesculap, Inc. is pleased to announce that the SterilContainer S product line has been cleared by the United States Food and Drug Administration (FDA), (510(k) number, K093649) for use in the STERIS Corporation's V-PRO 1 and V-PRO 1 Plus Low Temperature Sterilization Systems.
GlaxoSmithKline today announced the results of a U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) meeting to discuss the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).
A new study led by researchers from Mayo Clinic in collaboration with six other U.S. institutions has found that patients with non-Hodgkin's lymphoma who smoked, consumed alcohol or were obese before their cancer diagnosis had poorer overall survival, compared to patients who did not have these risk factors.
› Verified 9 days ago
| Entity Name | Metroplex Anesthesia Consultants, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427209790 PECOS PAC ID: 2062576119 Enrollment ID: O20090204000312 |
News Archive
Among the first and most-documented symptoms of autism spectrum disorder is a child's aversion to interaction with others. Specifically, they appear uninterested in social activities and stimuli that would normally attract a young child's attention, such as watching other children play, sing or dance.
Aesculap, Inc. is pleased to announce that the SterilContainer S product line has been cleared by the United States Food and Drug Administration (FDA), (510(k) number, K093649) for use in the STERIS Corporation's V-PRO 1 and V-PRO 1 Plus Low Temperature Sterilization Systems.
GlaxoSmithKline today announced the results of a U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) meeting to discuss the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).
A new study led by researchers from Mayo Clinic in collaboration with six other U.S. institutions has found that patients with non-Hodgkin's lymphoma who smoked, consumed alcohol or were obese before their cancer diagnosis had poorer overall survival, compared to patients who did not have these risk factors.
› Verified 9 days ago
| Entity Name | Endo Sedation Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588931174 PECOS PAC ID: 4789845363 Enrollment ID: O20120406000221 |
News Archive
Among the first and most-documented symptoms of autism spectrum disorder is a child's aversion to interaction with others. Specifically, they appear uninterested in social activities and stimuli that would normally attract a young child's attention, such as watching other children play, sing or dance.
Aesculap, Inc. is pleased to announce that the SterilContainer S product line has been cleared by the United States Food and Drug Administration (FDA), (510(k) number, K093649) for use in the STERIS Corporation's V-PRO 1 and V-PRO 1 Plus Low Temperature Sterilization Systems.
GlaxoSmithKline today announced the results of a U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) meeting to discuss the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).
A new study led by researchers from Mayo Clinic in collaboration with six other U.S. institutions has found that patients with non-Hodgkin's lymphoma who smoked, consumed alcohol or were obese before their cancer diagnosis had poorer overall survival, compared to patients who did not have these risk factors.
› Verified 9 days ago
| Entity Name | Arlington Anesthesia Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023483153 PECOS PAC ID: 2860798303 Enrollment ID: O20160310000125 |
News Archive
Among the first and most-documented symptoms of autism spectrum disorder is a child's aversion to interaction with others. Specifically, they appear uninterested in social activities and stimuli that would normally attract a young child's attention, such as watching other children play, sing or dance.
Aesculap, Inc. is pleased to announce that the SterilContainer S product line has been cleared by the United States Food and Drug Administration (FDA), (510(k) number, K093649) for use in the STERIS Corporation's V-PRO 1 and V-PRO 1 Plus Low Temperature Sterilization Systems.
GlaxoSmithKline today announced the results of a U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) meeting to discuss the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).
A new study led by researchers from Mayo Clinic in collaboration with six other U.S. institutions has found that patients with non-Hodgkin's lymphoma who smoked, consumed alcohol or were obese before their cancer diagnosis had poorer overall survival, compared to patients who did not have these risk factors.
› Verified 9 days ago
| Entity Name | Sound Physicians Anesthesiology Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295356277 PECOS PAC ID: 1254751407 Enrollment ID: O20201009000612 |
News Archive
Among the first and most-documented symptoms of autism spectrum disorder is a child's aversion to interaction with others. Specifically, they appear uninterested in social activities and stimuli that would normally attract a young child's attention, such as watching other children play, sing or dance.
Aesculap, Inc. is pleased to announce that the SterilContainer S product line has been cleared by the United States Food and Drug Administration (FDA), (510(k) number, K093649) for use in the STERIS Corporation's V-PRO 1 and V-PRO 1 Plus Low Temperature Sterilization Systems.
GlaxoSmithKline today announced the results of a U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) meeting to discuss the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).
A new study led by researchers from Mayo Clinic in collaboration with six other U.S. institutions has found that patients with non-Hodgkin's lymphoma who smoked, consumed alcohol or were obese before their cancer diagnosis had poorer overall survival, compared to patients who did not have these risk factors.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Esteban A Perez, CRNA 1702 N Ed Carey Dr, Harlingen, TX 78550-8202 Ph: (956) 423-4589 | Esteban A Perez, CRNA 2101 Pease St, Harlingen, TX 78550-8307 Ph: (956) 389-1100 |
News Archive
Among the first and most-documented symptoms of autism spectrum disorder is a child's aversion to interaction with others. Specifically, they appear uninterested in social activities and stimuli that would normally attract a young child's attention, such as watching other children play, sing or dance.
Aesculap, Inc. is pleased to announce that the SterilContainer S product line has been cleared by the United States Food and Drug Administration (FDA), (510(k) number, K093649) for use in the STERIS Corporation's V-PRO 1 and V-PRO 1 Plus Low Temperature Sterilization Systems.
GlaxoSmithKline today announced the results of a U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) meeting to discuss the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).
A new study led by researchers from Mayo Clinic in collaboration with six other U.S. institutions has found that patients with non-Hodgkin's lymphoma who smoked, consumed alcohol or were obese before their cancer diagnosis had poorer overall survival, compared to patients who did not have these risk factors.
› Verified 9 days ago
Mr. Jose L Garcia Iii, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2101 Pease St, Harlingen, TX 78550 Phone: 956-867-2530 | |
Helen Delores Padgett, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2101 Pease St, Harlingen, TX 78550 Phone: 956-389-1100 Fax: 956-389-1800 | |
Mr. Rene Lee Acosta, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3202 Tucker Rd, Harlingen, TX 78552 Phone: 956-536-7363 | |
Robin Melinda Woodard, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2101 Pease St, Harlingen, TX 78550 Phone: 956-389-1100 Fax: 956-389-1800 | |
Gonzalo Flores, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2101 Pease St, Harlingen, TX 78550 Phone: 956-389-1100 Fax: 956-389-1800 | |
Perla C Rufo, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2101 Pease St, Harlingen, TX 78550 Phone: 956-389-1100 Fax: 956-389-1800 | |
Jessica L Appel, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2101 Pease St, Harlingen, TX 78550 Phone: 956-389-1100 Fax: 956-389-1800 |